Medicinal Chemistry
Title:The Coronavirus Epidemic
Volume: 16 Issue: 3
Author(s): A. Hilgeroth
Affiliation:
Export Options
About this article
Cite this article as:
Hilgeroth A. , The Coronavirus Epidemic, Medicinal Chemistry 2020; 16 (3) . https://dx.doi.org/10.2174/157340641603200226092100
DOI https://dx.doi.org/10.2174/157340641603200226092100 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
7
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Current Medicinal Chemistry COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for Novel-Coronavirus 2019
Coronaviruses Yoga may Prevent Cytokine Storm in COVID-19
Coronaviruses COVID-19: Perspectives on the Potential Novel Global Threat
Reviews on Recent Clinical Trials The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise
Current Molecular Medicine Understanding Helicases as a Means of Virus Control
Current Pharmaceutical Design Expression of a Tagless Single-Chain Variable Fragment (scFv) of Anti-TNF-α by a Salt Inducible System and its Purification and Characterization
Protein & Peptide Letters Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters
Current Drug Metabolism Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Current Pharmaceutical Design The Role of Nutrition During the COVID-19 Pandemic: What We Know
Endocrine, Metabolic & Immune Disorders - Drug Targets SARS-CoV-2: An Insight into Detection Tools
Infectious Disorders - Drug Targets COVID-19 and Renal Diseases: An Update
Current Drug Targets A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
Coronaviruses A Generic Computer-Assisted Four-Pronged Approach for the Management of Emerging Global Pathogens: Some Comments on COVID-19
Current Computer-Aided Drug Design Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV)
Current Medicinal Chemistry Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Current Pharmaceutical Design A Comparative Analysis of Protein Interfaces
Protein & Peptide Letters Major Drugs Used in COVID-19 Treatment: Molecular Mechanisms, Validation and Current Progress in Trials
Coronaviruses Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research
Current Neurovascular Research Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread
Coronaviruses